The Australian Bragg Centre will be built in the Adelaide BioMed Precinct alongside its sister building the South Australian Health and Medical Research Institute (SAHMRI).
When in full operation, it is estimated as many as 600 to 700 patients will be able to be treated at the facility each year – with around half of these expected to be children and young adults.
As well as hosting the Australian Bragg Centre for Proton Therapy and Research, the 12-level building is also expected to be home to the SAiGEN Cancer Institute, a new independent genomics and immunotherapy centre dedicated to cancer research.
The new building will be developed and owned by SA developer Commercial and General and built by Lendlease.
Commercial and General, which recently completed the $345 million Calvary Adelaide Hospital in the CBD, is providing almost $400 million in project finance and has worked in collaboration with SAHMRI to develop the business case.
The Federal Government is providing $68 million through a National Partnership Agreement.
The State Government, which will be a cornerstone tenant through SA Health, is chipping in $47.4 million, including a $10.6 million grant to assist in the planning and development phase and $36.8 million to relocate the Train Control Centre from North Terrace to Dry Creek, making the site ready for development.
Construction is expected to be completed in late 2023 with the first patients treated about 18 months later.
The $500 million project will feature a ProTom International Radiance 330 proton therapy system on the building’s three basement levels. It is the same unit as the one used at Massachusetts General Hospital in Boston and will be one of only three of its kind in the world.
The original SAHMRI building opened in 2013 as the flagship site on the North Terrace health precinct and soon became known by locals as 'The Cheese Grater' for its stunning contemporary design.
Adelaide BioMed City is now a $3 billion tripartite health hub following the addition of the new Royal Adelaide Hospital (2016), the University of Adelaide’s Health and Medical Sciences Building in 2017 and the University of South Australia’s Cancer Research Institute (2018). A Women’s and Children’s hospital is also planned for the precinct's western corner.
SAHMRI executive director Professor Steve Wesselingh says the Australian Bragg Centre will be built on the emerging technology of proton therapy.
“The building’s three underground levels are dedicated to a facility that will not only deliver life-saving treatment to cancer patients, in particular children, but will also provide potential for research to unlock further benefits of this relatively new field and be a training ground for proton therapy specialists from throughout the Asia Pacific region and beyond,” he says.
“This building will also facilitate innovation spanning a range of fields including research and development, clinical trials and training.”